Procter & Gamble Health Limited (NSE:PGHL)
5,662.00
+12.00 (0.21%)
At close: Dec 19, 2025
Procter & Gamble Health Revenue
Procter & Gamble Health had revenue of 3.25B INR in the quarter ending September 30, 2025, with 3.67% growth. This brings the company's revenue in the last twelve months to 12.84B, up 10.75% year-over-year. In the fiscal year ending March 31, 2025, Procter & Gamble Health had annual revenue of 12.18B with 5.80% growth.
Revenue (ttm)
12.84B
Revenue Growth
+10.75%
P/S Ratio
7.30
Revenue / Employee
9.69M
Employees
1,326
Market Cap
93.76B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 12.18B | 667.90M | 5.80% |
| Jun 30, 2024 | 11.51B | -783.60M | -6.37% |
| Jun 30, 2023 | 12.30B | 1.15B | 10.34% |
| Jun 30, 2022 | 11.14B | 1.06B | 10.48% |
| Jun 30, 2021 | 10.09B | 1.20B | 13.52% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sun Pharmaceutical Industries | 549.64B |
| Aurobindo Pharma | 325.14B |
| Cipla | 279.66B |
| Zydus Lifesciences | 244.94B |
| Apollo Hospitals Enterprise | 232.65B |
| Glenmark Pharmaceuticals | 159.97B |
| Alkem Laboratories | 138.90B |
| Mankind Pharma | 135.46B |
Procter & Gamble Health News
- 3 months ago - P&G Health appoints Shashank Srowthy as Executive Director and CFO, effective October 1 - Business Upturn
- 5 months ago - P&G Health shares surge 8% as Q1 revenue jumps 19.5% YoY to Rs 339 crore - Business Upturn
- 1 year ago - P&G Health Q2 FY25: Revenue rises 2.8% YoY to Rs 313.41 crore, net profit surges 25.6% to Rs 82.33 crore - Business Upturn
- 1 year ago - Procter & Gamble Health Q2 FY25 results: Stock jumps 2% ahead of result announcement - Business Upturn